NCT06359535

An Economic Study of HSK21542 Injection for Prevention of Postoperative Nausea and Vomiting

An Economic Study on Prevention of Postoperative Nausea and Vomiting by HSK21542 Injection

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Mengchang Yang · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study analyzed the efficacy and safety results of HSK21542 injection for the prevention of postoperative nausea and vomiting in a multicentre, randomized, double-blind, placebo-controlled dose-exploration study, as well as the real-world clinical routine use of troisisone and other (not limited to other setron drugs) for the prevention of postoperative nausea and vomiting and related adverse reaction treatment data. It was transformed into an effect indicator, and the possible costs involved in the study were analyzed, reasonable price parameters of HSK21542 injection were set, and the economic value of HSK21542 was explored.

Conditions

• Nausea and Vomiting, Postoperative

Interventions

Type	Name	Description
DRUG	HSK21542	This study is an economic study and does not interfere with patients' medical treatment.
DRUG	Placebo	Placebo

Timeline

• Start date: 2024-02-23
• Primary completion: 2024-11-06
• Completion: 2024-11-06
• First posted: 2024-04-11
• Last updated: 2024-04-11

Locations

1 site across 1 country: China